SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MAXY - Maxygen, Inc.
An SI Board Since December 1999
Posts SubjectMarks Bans Symbol
262 30 0 MAXY
Emcee:  westpacific Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
237maxygen.com Some prelim int results on G34 from Cowen's presentation.dr.praveen-3/22/2007
236Roche had a portfolio cleansing the past week, scrapped the lead epothilone withrkrw-3/16/2007
235A drug development deal between two companies is like 2 people saying they will kenhott-3/16/2007
234My post was a response to kenhott's. I think it makes sense when viewed in keokalani'nui-3/15/2007
233<i>It's a virtue when you can will the future.</i> Maybe I shouSteve Lokness-3/15/2007
232You infer I implied the decision was Howard's and not Roche's? Don'keokalani'nui-3/15/2007
231Are you suggesting the decision was Howards and not Roche?Steve Lokness-3/15/2007
230Apt description. It's a virtue when you can will the future.keokalani'nui-3/15/2007
229Interesting. Thanks.nigel bates-3/15/2007
228Here is link to MT article I mentioned; technologyreview.comSteve Lokness-3/15/2007
227<just seems really weird to me> I guess if we look at it from the other skenhott-3/15/2007
226<i>The co-development and commercialization collaboration, which will offiSteve Lokness-3/14/2007
225Something is not exactly right at MAXY. Something along the dysfunctional line.kenhott-3/14/2007
224Maxy off only a dime. I suppose that's good even if the conclusion is everyokeokalani'nui-3/14/2007
223You're long gtcb? I had no idea.rkrw-3/13/2007
222Endogenous FVIIa is a remarkable substance and it really doesn’t need to be enhaDewDiligence_on_SI-3/13/2007
221Although I had that up front in my own report I didn't attribute it and I cakeokalani'nui-3/13/2007
220When did they say mid 07 ind? I had thought it had a lot longer to go.rkrw-3/13/2007
219"Under the terms of the Agreement, the Company and Roche had agreed to shardr.praveen-3/13/2007
218With the pre clinicals on Factor VII taking so long, Roche might have had a verydr.praveen-3/13/2007
217From "IND Mid-07" to loss of partner for failure to agree on a pre-clikeokalani'nui-3/13/2007
216REDWOOD CITY, Calif., March 13 /PRNewswire-FirstCall/ - Maxygen, Inc. (Nasdaq: Mkeokalani'nui-3/13/2007
215Chances for Novoseven program to work in ICH are low. BTW there is a follow on cdr.praveen-2/26/2007
214ICH is a very small part of NovoSeven sales, but it could have amounted to a nicDewDiligence_on_SI-2/26/2007
213Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, bkeokalani'nui-2/26/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News